FDA Rejects PTC Therapeutics’ Friedreich’s Ataxia Drug
The FDA has rejected PTC Therapeutics’ vatiquinone, the corporate’s proposed remedy for Friedreich’s ataxia in youngsters and adults.In its full...
Pharmaceutical Updates
Boehringer Ingelheim marks retinal illness push with $327m licensing deal
The attention illness market is at present dominated by anti-vascular endothelial development issue (VEGF) remedies. Credit score: Tada Pictures /...
well being care CEO internet price, Stealth, Novo
Need to keep on prime of the science and politics driving biotech right this moment? Enroll to get our biotech e-newsletter in...
Precigen Wins First FDA Immunotherapy Nod for Recurrent Respiratory Papillomatosis
The FDA on Thursday signed off on Precigen’s immunotherapy zopapogene imadenovec-drba for the therapy of adults with recurrent respiratory papillomatosis....
Sanofi’s Tzield secures MHRA go-ahead for sort 1 diabetes
Sanofi’s disease-modifying sort 1 diabetes drug, Tzield, has been permitted by the MHRA. Picture credit score: VCG / Contributor, Visible...
Novo Nordisk’s weight problems drug Wegovy cleared to deal with stay illness MASH
Novo Nordisk’s weight problems drug Wegovy was cleared by U.S. regulators on Friday to deal with an more and more...
2025 Q2 Job Market Report: Quartlery Job Postings Decline for Third Straight Quarter
Discovering or altering biopharma jobs seemingly proved troublesome for some within the second quarter, based mostly on BioSpace information. Throughout...
UK chikungunya circumstances rise amid vaccine security considerations
Chikungunya circumstances are up 170% within the UK, whereas Ixchiq, one of many two vaccines authorised for this indication, stays...
Drugmakers kind new group to foyer on impression of Medicare drug value negotiation
WASHINGTON — A handful of drug firms have shaped a bunch to current lawmakers with analysis on what the trade...
Technology Bio Boots 90% of Employees Amid Dwindling Money Reserves
Technology Bio will shed 90% of its workforce amid a money crunch that might render the biotech unable to help...
Podcast: US tariff information and Q2 earnings affect pharma developments
The editorial workforce investigates the influence of US Tariffs on the pharmaceutical sector and discusses main developments from the Q2...
Vinay Prasad, Vertex, mRNA vaccines, HHS
Need to keep on prime of the science and politics driving biotech immediately? Enroll to get our biotech publication in your inbox....
140-12 months-Previous Boehringer Ingelheim Dives Into Most cancers With NSCLC Nod
The FDA signed off on Boehringer Ingelheim’s kinase inhibitor zongertinib for the remedy of sure sufferers with non-small cell lung...
EpiPen patent expiry opens new period for innovation
The EpiPen patent held by Viatris is expiring on 11 September 2025. Picture credit score: Photograph Nature Journey by way...
Vinay Prasad returns to the FDA, weeks after his ouster
WASHINGTON — Vinay Prasad is returning to the Meals and Drug Administration to renew his position overseeing vaccine, gene remedy,...
